The Intersecting Pathways of Autism Spectrum Disorder, Polycystic Ovary Syndrome, and Gender Dysphoria: A Comprehensive Review of the Epidemiological and Biological Evidence

I. Introduction: A Triad of Neurodevelopmental, Endocrine, and Identity Constructs

Overview of the Converging Evidence

In recent years, clinical observations and empirical research have begun to illuminate a complex and unexpected intersection between three distinct clinical entities: Autism Spectrum Disorder (ASD), a neurodevelopmental condition defined by challenges in social communication and the presence of restricted, repetitive behaviors; Polycystic Ovary Syndrome (PCOS), a common endocrine and metabolic disorder characterized by hyperandrogenism and ovulatory dysfunction; and Gender Dysphoria (GD), a condition of clinically significant distress arising from an incongruence between an individual's experienced gender and their sex assigned at birth. The burgeoning evidence of their co-occurrence has sparked significant interest, challenging the traditional silos of medicine and psychology that have historically separated the domains of neurodevelopment, endocrinology, and identity.¹ This convergence suggests that the underlying biological pathways may not be domain-specific but rather fundamental to human development, with wide-ranging effects across multiple physiological and psychological systems. The investigation into these links is not merely a clinical curiosity; it represents a critical area of inquiry that may hold profound implications for understanding the etiologies of these conditions and for developing more integrated and effective models of care.

The observation that these three seemingly disparate conditions may be linked points toward the existence of shared underlying biological mechanisms. A simple model of co-morbidity is likely insufficient to explain a three-way association. A more parsimonious explanation involves a common etiological factor or pathway that influences brain development, endocrine function, and the formation of identity. The most prominent and unifying theoretical framework proposed to date is the prenatal sex steroid hypothesis, which posits that exposure to elevated levels of hormones, particularly androgens, during critical windows of fetal development can simultaneously influence the neurodevelopmental trajectories associated with ASD, the endocrine dysregulation characteristic of PCOS, and the sexual differentiation of the brain that is believed to underpin gender identity.³ This report will demonstrate that the co-occurrence of these conditions is not a random clinical finding but a powerful clue pointing towards fundamental developmental processes that have been underappreciated in their scope and impact.

Statement of the Report's Objective and Scope

The objective of this report is to provide an exhaustive and critical synthesis of the current epidemiological and biological evidence linking Autism Spectrum Disorder, Polycystic Ovary Syndrome, and Gender Dysphoria. The scope of this analysis is comprehensive, encompassing a detailed review of the diagnostic frameworks for each condition, a critical evaluation of the prevalence data that establishes their co-occurrence, an in-depth analysis of the leading etiological theories—with a primary focus on the prenatal sex steroid hypothesis—and a thorough discussion of the complex clinical implications for diagnosis, management, and patient care. Throughout this review, a critical perspective will be maintained, carefully distinguishing established statistical correlations from speculative or unproven causal relationships.⁶ By integrating findings from neurodevelopmental science, endocrinology, genetics, and psychiatry, this report aims to construct a coherent narrative that illuminates the state of current knowledge, identifies critical research gaps, and provides a foundation for future inquiry into this important triad.

II. Clinical and Biological Foundations of Each Condition

2.1. Autism Spectrum Disorder (ASD)

Diagnostic Framework (DSM-5)

Autism Spectrum Disorder is a neurodevelopmental condition defined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), by a dyad of core features: (A) persistent deficits in social communication and social interaction across multiple contexts, and (B) restricted, repetitive patterns of behavior, interests, or activities.⁷ To receive a diagnosis, an individual must exhibit deficits in all three subdomains of social communication and interaction. These include difficulties in social-emotional reciprocity, such as trouble with conversational back-and-forth or sharing interests; deficits in nonverbal communicative behaviors, such as abnormal eye contact, body language, or understanding of gestures; and challenges in developing, maintaining, and understanding relationships appropriate to their developmental level.⁹

The second core feature requires the presence of at least two of four types of restricted and repetitive behaviors. These include stereotyped or repetitive motor movements, use of objects, or speech (e.g., hand-flapping, lining up toys, echolalia); insistence on sameness, inflexible adherence to routines, or ritualized patterns of behavior, often accompanied by extreme distress at small changes; highly restricted, fixated interests that are abnormal in intensity or focus; and hyper- or hyporeactivity to sensory input or unusual interest in sensory aspects of the environment, such as indifference to pain or an adverse response to specific sounds or textures.⁸

Neurobiological and Genetic Basis

ASD is understood to be a condition related to differences in brain development and connectivity, with a strong biological basis.¹¹ It is highly heritable, and research indicates that several genes are involved, some of which may affect brain development, how brain cells communicate, or the severity of symptoms.¹⁰ While some genetic variations appear to be inherited, others may arise spontaneously. In some cases, ASD is associated with specific genetic conditions like Fragile X syndrome or Rett syndrome.¹¹ In addition to genetic factors, researchers are actively exploring the role of environmental influences, such as prenatal viral infections, certain medications, complications during pregnancy, or exposure to air pollutants, which may act in concert with genetic predispositions to increase the risk of ASD.¹¹ ASD is also associated with a high rate of co-occurring psychiatric conditions, with Attention-Deficit/Hyperactivity Disorder (ADHD) being the most common, alongside anxiety, depression, and mood disorders.¹⁰

Clinical Presentation and Severity

The term "spectrum" reflects the wide variation in the type and severity of symptoms that individuals with ASD experience. The DSM-5 specifies three functional levels of severity for each of the two core domains, which are determined by the degree of support an individual requires to function.⁷ Level 1, "Requiring Support," describes individuals who have noticeable impairments in social communication and whose restricted interests or repetitive behaviors interfere with functioning in one or more contexts. Level 2, "Requiring Substantial Support," applies to individuals with marked deficits in verbal and nonverbal communication, limited social initiations, and whose repetitive behaviors are obvious to a casual observer and interfere with functioning across various contexts. Level 3, "Requiring Very Substantial Support," is used for individuals with severe deficits in communication that cause severe impairments in functioning, very limited social interaction, and whose repetitive behaviors markedly interfere with all areas of functioning.⁷

2.2. Polycystic Ovary Syndrome (PCOS)

Diagnostic Framework (Rotterdam Criteria)

Polycystic Ovary Syndrome is the most common endocrine disorder among individuals of reproductive age, affecting an estimated 5-15% of this population.⁵ The most widely accepted diagnostic framework is the 2003 Rotterdam criteria, which requires the presence of at least two of the following three features for a diagnosis: (1) oligo- and/or anovulation, manifesting as irregular, infrequent, or absent menstrual periods; (2) clinical and/or biochemical signs of hyperandrogenism; and (3) polycystic ovarian morphology (PCOM) as identified by ultrasound.¹³ It is critical to note that PCOS is a diagnosis of exclusion, meaning other conditions that can mimic its symptoms, such as thyroid dysfunction, congenital adrenal hyperplasia, or androgen-secreting tumors, must be ruled out.¹⁴

Pathophysiology of Hyperandrogenism and Insulin Resistance

The pathophysiology of PCOS is complex and multifactorial, but its central features are hyperandrogenism (an excess of androgens like testosterone) and ovulatory dysfunction.¹⁵ In PCOS, the ovaries may produce high levels of androgens, which interfere with the development and regular release of eggs from the follicles, leading to irregular menstrual cycles and infertility.¹³ The clinical manifestations of this androgen excess include hirsutism (excess facial and body hair), persistent acne beyond adolescence, and androgenic alopecia (male-pattern hair thinning).¹³

A key contributing factor in approximately 70% of individuals with PCOS is insulin resistance, leading to compensatory hyperinsulinemia.¹⁵ Elevated insulin levels can stimulate the ovaries to produce even more androgens and can disrupt the normal hormonal feedback loops within the hypothalamic-pituitary-ovarian (HPO) axis, thereby exacerbating the cycle of anovulation and hyperandrogenism.¹³ This metabolic dysfunction is often present regardless of body weight but is more severe in individuals with obesity.¹⁵

Metabolic and Systemic Health Implications

PCOS is not merely a reproductive disorder but a lifelong condition with significant systemic health consequences. The underlying insulin resistance and chronic low-grade inflammation place individuals with PCOS at a substantially increased risk for a cluster of metabolic conditions.¹³ These include metabolic syndrome, type 2 diabetes, dyslipidemia (unhealthy cholesterol levels), and hypertension, all of which contribute to a higher risk of cardiovascular disease.¹³ Furthermore, the chronic anovulation and resulting unopposed estrogen exposure increase the risk of endometrial hyperplasia and endometrial cancer.¹⁵ Beyond the physical health risks, PCOS carries a significant psychological burden. The symptoms, including infertility, unwanted hair growth, acne, and weight gain, can lead to social stigma, negative body image, anxiety, and depression.¹⁷

2.3. Gender Dysphoria (GD)

Diagnostic Framework (DSM-5)

Gender Dysphoria is defined in the DSM-5 as the clinically significant distress or impairment in social, occupational, or other important areas of functioning that results from a marked and persistent incongruence between an individual's experienced or expressed gender and their assigned gender.¹⁸ It is essential to understand that gender non-conformity is not, in itself, a mental disorder.²¹ The diagnosis is not based on the presence of gender incongruence alone but on the associated distress it causes.²¹

For adolescents and adults, the diagnosis requires a duration of at least six months and the presence of at least two of several criteria. These include a marked incongruence between one's experienced gender and primary/secondary sex characteristics; a strong desire to be rid of one's sex characteristics; a strong desire for the sex characteristics of another gender; a strong desire to be, or to be treated as, another gender; and a strong conviction that one has the typical feelings and reactions of another gender.²⁰ The criteria for children are similar but require at least six symptoms, such as a strong preference for cross-gender roles in play, a preference for toys and playmates of another gender, and a strong dislike of one's sexual anatomy.²⁰

Neurobiological Theories of Gender Identity

The etiology of gender identity is not fully understood but is thought to involve a complex interplay of biological, genetic, and psychosocial factors.²² A prominent biological theory posits that gender identity is largely determined by the sexual differentiation of the brain, which occurs during critical prenatal and perinatal periods under the influence of sex hormones.²² This process of brain differentiation occurs later in gestation than the differentiation of the genitals. An incongruence between these two processes—for example, due to atypical levels of prenatal androgen exposure—could result in a brain that is organized in a manner more consistent with a gender identity that differs from the sex assigned at birth.¹⁹ This theory is supported by neuroanatomical studies that have found some brain structures and connectivity patterns in transgender individuals that more closely resemble those of their experienced gender rather than their assigned sex.¹⁹ Genetic factors also appear to play a role, with studies identifying associations between gender dysphoria and genes involved in sex hormone signaling.²⁴

Distinction from Related Concepts

To understand GD, it is crucial to distinguish several key terms. Sex assigned at birth refers to the designation (typically male or female) based on external genitalia at birth. Gender identity is a person's internal, deeply held sense of their own gender. Gender expression is the outward manifestation of gender through appearance, clothing, mannerisms, and behavior.²⁰ For many individuals, these align (cisgender), but for transgender and gender-diverse individuals, they do not. The primary treatment for GD is to alleviate the distress by helping the individual align their life and, if desired, their body with their gender identity. This process, known as

transition, can involve social changes (name, pronouns), legal changes (gender markers on documents), and medical interventions such as puberty suppression, gender-affirming hormone therapy, and surgeries.²⁰

Table 1: Comparative Diagnostic Criteria for ASD, PCOS, and Gender Dysphoria

Condition	Core Diagnostic Domain	Specific Criteria / Symptoms
Autism Spectrum Disorder (ASD)	A. Social Communication & Interaction	1. Deficits in social-emotional reciprocity (e.g., abnormal social approach, failure of back-and-forth conversation).7	2. Deficits in nonverbal communicative behaviors (e.g., poor eye contact, lack of facial expressions).8	3. Deficits in developing, maintaining, and understanding relationships.7
	B. Restricted, Repetitive Behaviors	1. Stereotyped or repetitive motor movements, use of objects, or speech (e.g., echolalia, hand-flapping).8	2. Insistence on sameness, inflexible adherence to routines, or ritualized patterns of behavior.7	3. Highly restricted, fixated interests that are abnormal in intensity or focus.7	4. Hyper- or hyporeactivity to sensory input or unusual sensory interests.7
Polycystic Ovary Syndrome (PCOS)	Endocrine-Metabolic Dysfunction	Requires 2 of the following 3 criteria (Rotterdam Criteria): 1. Ovulatory Dysfunction: Oligo- or anovulation (e.g., irregular periods, <8 cycles per year, cycles >35 days apart).13	2. Hyperandrogenism: Clinical signs (e.g., hirsutism, severe acne, male-pattern alopecia) OR biochemical evidence (e.g., elevated total or free testosterone).13	3. Polycystic Ovarian Morphology: Presence of multiple small follicles on the ovaries as seen on ultrasound.13
Gender Dysphoria (GD)	Incongruence & Distress	Marked incongruence between experienced/expressed gender and assigned gender, with associated clinically significant distress or impairment. Requires ≥2 symptoms for adolescents/adults: 1. Strong desire to be rid of one's primary and/or secondary sex characteristics.18	2. Strong desire for the primary and/or secondary sex characteristics of the other gender.18	3. Strong desire to be of the other gender.20	4. Strong desire to be treated as the other gender.20	5. Strong conviction that one has the typical feelings and reactions of the other gender.18

III. The Epidemiological Nexus: Quantifying the Overlap

3.1. The Robust Link Between Autism and Gender Dysphoria

A substantial and growing body of evidence demonstrates a significant and robust link between Autism Spectrum Disorder and gender diversity. Multiple large-scale studies and meta-analyses have consistently found that individuals who do not identify with the sex they were assigned at birth are significantly more likely to be autistic. The data suggest that gender-diverse people are three to six times as likely to have an ASD diagnosis compared to their cisgender peers.²⁶ A 2023 meta-analysis synthesizing 47 studies solidified this finding, calculating a pooled prevalence estimate of diagnosed ASD in individuals with Gender Dysphoria or Gender Incongruence (GD/GI) to be 11%.¹ This figure is strikingly higher than the estimated 1-2% prevalence of ASD in the general population, indicating a co-occurrence that is far greater than would be expected by chance.

This association extends beyond formal diagnoses to include subthreshold autistic traits. Studies have shown that gender-diverse individuals, on average, self-report a higher number of traits associated with autism, such as sensory sensitivities and difficulties with social-emotional reciprocity, even if they do not meet the full criteria for a diagnosis.²⁶ The overall effect size of the difference in autistic traits between GD/GI and control populations is statistically significant and moderate in magnitude (

g=0.67), further underscoring the strength of this connection.¹ This suggests that the relationship is not an artifact of diagnostic practices but reflects a genuine overlap in underlying neurobiology or cognitive styles.

Further research has begun to explore the nature of this co-occurrence, examining how gender diversity manifests in autistic individuals. Some early hypotheses suggested that autistic traits like cognitive rigidity might lead to a higher endorsement of binary (male or female) gender identities. However, recent cohort studies of transgender youth have not supported this; the distribution of binary versus non-binary identities appears to be similar between transgender young people with and without elevated autistic traits.²⁹ Interestingly, the same research identified subtle but important differences in the experience and expression of gender dysphoria. Transgender youth with autistic traits were found to have higher rates of social transition, specifically regarding pronoun changes, and reported more intense dysphoria related to their voice and certain hormonally unresponsive body characteristics.²⁹ These findings suggest that while the core gender identity may be similar, the way dysphoria is experienced and acted upon may be influenced by autistic neurotype.

3.2. The Bidirectional Association Between PCOS and Autism

The epidemiological evidence also reveals a compelling bidirectional association between Polycystic Ovary Syndrome and Autism Spectrum Disorder. This link has been established through large-scale, population-based studies that have examined the relationship from two directions: the risk of ASD in the offspring of mothers with PCOS, and the prevalence of PCOS in autistic individuals themselves.

Several major studies, most notably those utilizing comprehensive national health registers in Sweden and the UK, have demonstrated that a maternal diagnosis of PCOS is a significant risk factor for having a child with ASD. A landmark Swedish study found that maternal PCOS increased the odds of ASD in the offspring by 59% after adjusting for potential confounders.⁵ This risk was even more pronounced in mothers who had both PCOS and obesity—a condition often associated with more severe hyperandrogenism—with the odds ratio increasing to 2.13.³¹ Subsequent meta-analyses have confirmed this finding, calculating a pooled odds ratio of approximately 1.66, meaning women with PCOS have about a 66% increased chance of having a child with ASD.³²

The association is not limited to a unidirectional, prenatal environmental effect. Research has also established the reverse link: autistic individuals assigned female at birth have a significantly higher prevalence of PCOS. One large UK-based study found that autistic women had an almost two-fold increase in the risk for PCOS compared to their non-autistic peers.⁴ This bidirectionality is a critical finding. If the connection were purely a result of the prenatal hormonal environment created by a mother with PCOS, one would not necessarily expect the autistic offspring to have a higher personal risk of developing the same endocrine condition. The existence of both a maternal-to-offspring risk and a higher prevalence within the autistic population itself strongly suggests a more complex relationship involving shared underlying factors, such as common genetic predispositions (pleiotropy) or shared neuroendocrine pathways that confer susceptibility to both atypical neurodevelopment and endocrine dysfunction. This reframes the relationship from a simple risk factor model to a more sophisticated shared etiology model, where PCOS in the mother may be an indicator of a familial biological predisposition that can manifest differently across generations.

3.3. The Developing Picture of PCOS and Gender Identity

The potential link between PCOS and gender identity, particularly in transmasculine individuals (assigned female at birth, identify as male or on the masculine spectrum), is an area of active but still developing research. The biological plausibility for such a link is rooted in the hyperandrogenism central to PCOS, as androgens are known to play a role in the masculinization of the brain and body. Several studies have investigated this connection, yielding an intriguing but inconsistent set of findings.

Some research suggests a higher prevalence of PCOS among transmasculine individuals seeking gender-affirming care, even before the initiation of testosterone therapy. One study, for example, found that 22.9% of drug-naïve trans men met the Rotterdam criteria for PCOS, compared to 11.7% in a control group of cisgender women.³⁷ Other early studies reported even higher rates, sometimes exceeding 50%.³⁸ These findings are often coupled with observations that transmasculine individuals, as a group, tend to have higher baseline levels of circulating androgens than cisgender women.³⁷ Furthermore, some qualitative research indicates that individuals with PCOS are less likely to identify with traditionally feminine gender roles and may feel their symptoms disrupt Western conceptions of femininity.³⁹

However, this picture is complicated by contradictory findings and significant methodological limitations in the existing literature. Many of the early studies that reported very high PCOS prevalence rates were small, lacked appropriate control groups, or used inconsistent and outdated diagnostic criteria for PCOS, potentially leading to an overestimation of the association.³⁹ More recent and methodologically rigorous studies, which have employed standardized diagnostic criteria and included well-matched control groups, have failed to find a statistically significant difference in the prevalence of PCOS between transmasculine individuals and cisgender women.³⁹ This discrepancy highlights the critical need for further large-scale, well-controlled research to clarify the true prevalence. An interesting related finding from an adolescent cohort suggests that while overall PCOS rates may not differ, the degree of hirsutism—a direct clinical sign of androgen excess—was significantly associated with identifying as transgender.⁴² This suggests a complex interplay where the biological manifestation of hyperandrogenism may interact with the development or expression of gender identity.

Table 2: Summary of Key Epidemiological Findings on Co-occurrence

Condition Pair	Population Studied	Key Statistic	Value	Comparison	Key Studies
ASD & Gender Dysphoria	Individuals with Gender Dysphoria	Prevalence of ASD Diagnosis	~11%	3-6x higher odds than in cisgender population (~1-2% prevalence)	1
PCOS & ASD (Maternal Link)	Offspring of mothers with PCOS	Odds Ratio for ASD	OR≈1.59−1.66	59-66% increased odds of ASD diagnosis in offspring	5
PCOS & ASD (Individual Link)	Autistic women	Odds Ratio for PCOS	OR≈2.0	Approximately 2-fold increased odds of having PCOS	4
PCOS & Gender Dysphoria	Transmasculine individuals (pre-testosterone)	Prevalence of PCOS	Inconsistent (15% to >50%)	Evidence is mixed; some studies show higher rates, while recent, well-controlled studies show no significant difference from cisgender women	37

IV. Unifying Etiological Frameworks: The Prenatal Sex Steroid Hypothesis

4.1. Core Tenets of the Theory

The most compelling and integrative framework proposed to explain the observed co-occurrence of ASD, PCOS, and GD is the prenatal sex steroid hypothesis.⁴ The central tenet of this theory is that exposure to elevated levels of sex steroid hormones, particularly androgens such as testosterone, during critical windows of fetal development acts as a common biological antecedent that can influence multiple developmental pathways simultaneously.³ These hormones are known to have profound "organizational" effects on the developing central nervous system. The theory posits that atypical levels of these hormones can alter the trajectory of brain development, influencing neuronal proliferation, migration, and connectivity in ways that increase the likelihood of autistic traits.⁵ Concurrently, this same hormonal milieu is theorized to influence the sexual differentiation of the brain, establishing the neurobiological substrate of gender identity, which may develop incongruently with the differentiation of the genitals.²⁴ PCOS is intrinsically linked to this framework as a condition characterized by hyperandrogenism, which can both originate from and contribute to an elevated prenatal androgen environment.⁴

This hypothesis provides a unifying biological narrative that not only links the three conditions but also offers a plausible explanation for the well-documented male bias in autism prevalence. ASD is diagnosed approximately three to four times more often in individuals assigned male at birth.⁴ The prenatal sex steroid theory provides a direct, biologically grounded mechanism for this disparity. Male fetuses are, on average, exposed to a significant surge of testosterone prenatally, which is crucial for masculinization of the body and brain. If elevated androgens are indeed a risk factor for ASD, then male fetuses inherently have a higher baseline exposure to this risk factor. For a female fetus to reach a similar risk threshold, an additional source of elevated androgens would be required. Maternal PCOS provides precisely such a source, creating a hyperandrogenic uterine environment that exposes fetuses of both sexes to higher-than-typical androgen levels.⁵ This explains the epidemiological finding that maternal PCOS increases ASD risk in both male and female offspring.⁵ In effect, the hormonal environment of a pregnancy affected by PCOS may partially "masculinize" the prenatal milieu for a female fetus, pushing her closer to the neurodevelopmental risk threshold typically associated with males. Thus, the theory elegantly integrates three key observations: the PCOS-ASD link, the role of androgens in brain development, and the male bias in ASD prevalence.

4.2. Evidence Linking Prenatal Androgens to Autism

Support for the role of prenatal androgens in the etiology of autism comes from several lines of direct and indirect evidence. The most direct evidence is derived from studies that have analyzed hormone levels in amniotic fluid samples collected during gestation. This research has found a significant positive correlation between the concentration of fetal testosterone and other steroid hormones in the amniotic fluid and the subsequent diagnosis of ASD or the number of autistic traits observed in the child during toddlerhood and later childhood.⁴ These findings suggest that higher levels of prenatal androgen exposure are associated with a neurodevelopmental trajectory that is more likely to result in an autistic phenotype.

This hormonal evidence is often situated within the broader, though controversial, "Extreme Male Brain" theory of autism.³⁴ This theory posits that autism may represent an extreme manifestation of certain male-typical cognitive and behavioral profiles, such as enhanced systemizing (the drive to analyze or construct systems) and reduced empathizing. Since these psychological characteristics are themselves associated with prenatal testosterone levels, the theory suggests that the elevated prenatal androgens observed in association with autism may be the driving force behind this cognitive profile.³⁵ While the theory remains a subject of debate, it has been instrumental in focusing research attention on the role of prenatal sex steroids in shaping the neurodevelopmental pathways relevant to autism.

4.3. Evidence Linking Prenatal Androgens to Gender Identity

The biological basis of gender identity is also thought to be heavily influenced by the hormonal environment during prenatal development. The process of sexual differentiation of the brain, which is believed to establish the neural foundations of gender identity, occurs at a different and later stage of gestation than the sexual differentiation of the genitals.²⁴ These two processes, while typically aligned, can be influenced independently. A core tenet of the neurobiological theory of gender identity is that an incongruence between the hormonal signaling that directs genital development and the hormonal signaling that directs brain differentiation can result in a gender identity that does not align with the sex assigned at birth.²⁴

Compelling evidence for this hormonal influence comes from the study of individuals with Disorders of Sex Development (DSDs). For example, individuals with a 46,XX karyotype who have Congenital Adrenal Hyperplasia (CAH) are exposed to high levels of androgens in utero due to an enzyme deficiency. Despite being assigned female and raised as girls, they show a significantly higher prevalence of gender variance and gender dysphoria compared to the general population.³⁹ Similarly, individuals with a 46,XY karyotype and 5-alpha-reductase deficiency are born with ambiguous or female-typical genitalia due to impaired conversion of testosterone to a more potent androgen. Many are raised as girls, but at puberty, a surge in testosterone causes virilization, and a majority subsequently adopt a male gender identity.³⁹ These "natural experiments" provide strong evidence that prenatal and pubertal androgen exposure plays a crucial role in shaping the development of gender identity.

4.4. PCOS as a "Natural Experiment"

The condition of Polycystic Ovary Syndrome serves as a powerful human model, or "natural experiment," for testing the predictions of the prenatal sex steroid hypothesis. PCOS is fundamentally a disorder of androgen excess, and this hyperandrogenic state can persist during pregnancy, thereby creating a prenatal environment with higher-than-typical levels of androgens for the developing fetus.⁵ The robust epidemiological finding that maternal PCOS significantly increases the risk of an ASD diagnosis in offspring provides strong, albeit indirect, support for the theory.⁴

This association allows researchers to link a naturally occurring hyperandrogenic condition in the mother to a specific neurodevelopmental outcome in her child, strengthening the causal inference that prenatal androgen exposure is a relevant etiological factor for autism. The fact that this increased risk is observed in offspring of both sexes further bolsters the hypothesis, suggesting that the elevated hormonal environment can influence neurodevelopment regardless of the fetus's own genetic sex.³¹ Therefore, the study of PCOS and its neurodevelopmental sequelae in offspring is a critical avenue of research that bridges endocrinology and developmental neuroscience, providing valuable insights into the hormonal antecedents of autism.

V. Intersecting Pathways Beyond Hormones: Genetics, Neuroendocrinology, and Environment

5.1. Shared Genetic Architecture

While the prenatal sex steroid hypothesis provides a compelling narrative, it is likely that hormones do not act in isolation but interact with an underlying genetic architecture. The bidirectional nature of the PCOS-ASD link—where maternal PCOS increases offspring ASD risk, and autistic individuals themselves have a higher prevalence of PCOS—strongly points toward shared genetic factors.⁵ It is plausible that certain genetic loci or pathways confer a dual susceptibility to both endocrine dysregulation and atypical neurodevelopment. Genome-wide association studies (GWAS) have begun to identify genetic variants associated with PCOS, many of which are involved in pathways related to insulin signaling, gonadotropin action, and ovarian steroidogenesis.¹⁵ Future research may reveal that some of these same genes or pathways are also implicated in the genetic risk for ASD, a concept known as pleiotropy, where one gene influences two or more seemingly unrelated phenotypic traits. Identifying such shared genetic underpinnings would provide a powerful molecular explanation for the observed co-occurrence.

5.2. The Hypothalamic-Pituitary-Adrenal (HPA) Axis and Stress

The body's central stress response system, the Hypothalamic-Pituitary-Adrenal (HPA) axis, represents another potential intersecting pathway. The HPA axis is intricately linked with the reproductive Hypothalamic-Pituitary-Gonadal (HPG) axis, and its dysregulation is implicated in the pathophysiology of PCOS.¹⁵ Concurrently, there is growing evidence for HPA axis abnormalities in individuals with ASD. A novel theory posits that excessive or prolonged stress during the pre-, peri-, or postnatal periods can lead to chronically elevated levels of corticotropin-releasing hormone (CRH), the primary regulator of the HPA axis.⁴⁵ This chronic CRH elevation is hypothesized to be a core factor in the development of ASD symptoms. Importantly, CRH not only drives the stress response but also influences the release of adrenal androgens. Therefore, HPA axis dysregulation due to early life stress could be a common mechanism that contributes to both the neurodevelopmental features of ASD and the hormonal imbalances (including elevated adrenal androgens) seen in conditions like PCOS.⁴⁵

5.3. Immune System Dysregulation

There is emerging evidence to suggest that immune system dysregulation may be a common thread linking neurodevelopmental, endocrine, and identity-related conditions. Research has identified an intriguing association between autoimmune thyroiditis (e.g., Hashimoto's disease) and all three conditions of interest. Studies have noted higher rates of autoimmune thyroid disease in lesbian women and transmasculine individuals, a strong comorbidity between thyroid autoimmunity and PCOS, and an increased risk of ASD in the offspring of mothers with thyroid autoimmunity during pregnancy.⁴⁶ This suggests a broader pattern of neuro-endocrine-immune system dysregulation that may predispose individuals to a range of interconnected conditions. The precise mechanisms are still under investigation but could involve inflammatory processes or antibodies that cross-react with tissues in the brain and endocrine glands during critical developmental periods.

5.4. Environmental Factors and Endocrine Disrupting Chemicals (EDCs)

Finally, environmental exposures may interact with genetic predispositions to contribute to the risk of these conditions. Endocrine-disrupting chemicals (EDCs) are exogenous substances, common in the modern environment, that can interfere with the body's hormonal systems.⁴⁷ Chemicals such as phthalates (found in plastics) and polychlorinated biphenyls are known to disrupt normal sex hormone signaling. Because the placenta is not an effective barrier, these chemicals can cross from the mother to the fetus during gestation.⁴⁷ Exposure to EDCs during critical windows of fetal development has been associated with an increased risk of both ASD and GD.¹⁹ This represents a potential gene-environment interaction, where an individual with a genetic susceptibility might only develop a condition if exposed to a specific environmental trigger like an EDC. This pathway provides another plausible mechanism through which the hormonal milieu of the fetus can be altered, leading to long-term consequences for neurodevelopment and endocrine function.

VI. Clinical Implications and Integrated Management Strategies

6.1. Diagnostic Challenges and the Need for Cross-Disciplinary Screening

The significant co-occurrence of ASD, PCOS, and GD presents considerable diagnostic challenges for clinicians, stemming from the potential for symptomatic overlap and the need for expertise across multiple disciplines. For instance, the social difficulties inherent to ASD, such as challenges with peer relationships and social reciprocity, could be misinterpreted as social withdrawal secondary to the distress of GD or the negative body image issues associated with PCOS symptoms like hirsutism or acne.⁴⁸ Conversely, the intense focus on gender-related topics in an individual with GD might be mistaken for a restricted interest characteristic of ASD. Furthermore, the cognitive rigidity or "black-and-white" thinking common in autism could be misconstrued as an unyielding insistence on a particular gender identity, necessitating a careful, nuanced, and extended assessment process to differentiate core identity from cognitive style.⁴⁹

Given the high rates of co-occurrence, a paradigm shift towards routine cross-disciplinary screening is warranted. Healthcare providers treating gender-diverse individuals should be trained to recognize the signs of ASD and should consider formal screening, particularly when social or communication challenges are present.⁵¹ Similarly, professionals working with the autistic population, especially those assigned female at birth, should be aware of the increased likelihood of gender diversity and be prepared to explore questions of gender identity in a sensitive and affirming manner. They should also be vigilant for the clinical signs of PCOS, such as menstrual irregularities, and facilitate appropriate endocrinological evaluation when indicated.⁴²

6.2. Models for Integrated and Tailored Care

The complexity of managing these co-occurring conditions necessitates a move away from siloed care towards integrated, multidisciplinary models. The ideal care team would consist of professionals with expertise in all relevant domains, including endocrinology, psychiatry or psychology (with expertise in both autism and gender), developmental pediatrics, and primary care.⁵¹ This collaborative approach ensures that all aspects of an individual's health—neurodevelopmental, endocrine, and mental—are addressed cohesively.

Crucially, gender-affirming care must be thoughtfully tailored to meet the unique needs of autistic individuals. The standard assessment process may need to be extended to allow sufficient time for the individual to explore their identity and for the clinical team to fully understand the interplay between their autism and their gender experience.⁵¹ Communication strategies must be adapted to the individual's specific profile, utilizing clear, concrete language and visual aids where helpful. Interventions must also account for autistic traits such as sensory sensitivities, which might impact tolerance for hormone injections, medication textures, or post-surgical garments. Resistance to change, another core autistic trait, can make the physical and social transitions associated with gender affirmation particularly challenging, requiring additional psychological support and preparation.⁵⁰ Recent research indicating that autistic transgender youth may experience more intense dysphoria related to specific features like their voice suggests that therapeutic interventions, such as voice therapy, may need to be prioritized for this population.²⁹

The presence of autism also fundamentally alters the process of informed consent for gender-affirming medical interventions, which often have irreversible consequences. While an autism diagnosis does not preclude an individual's capacity to consent, it does require a more supportive and scaffolded clinical approach. Clinicians must carefully and collaboratively explore the individual's understanding of the proposed treatments, the potential risks and benefits, and their long-term goals. The process must differentiate a stable, core gender identity from influences of autistic traits like cognitive rigidity or a temporary special interest. This does not invalidate the person's identity but rather underscores the need for a developmental, supportive, and exploratory model of care that honors the individual's autonomy while ensuring they can navigate the complex decision-making process effectively.⁵⁰

6.3. Addressing the High Burden of Co-morbid Mental Health Conditions

A critical aspect of managing this triad is addressing the exceptionally high burden of co-morbid mental health conditions. Each of these three populations—autistic individuals, people with PCOS, and gender-diverse individuals—independently experiences significantly elevated rates of anxiety, depression, substance use disorders, and suicidality when compared to the general population.¹⁰ Research indicates that individuals with GD exhibit high rates of depressive symptoms (64%) and suicidality (42.9%).⁵³

The co-occurrence of these conditions likely creates a synergistic or compounding effect, imposing a particularly severe and distressing burden on the individual and further increasing the risk of self-harm and suicide.¹ This elevated risk stems from multiple sources, including the internal distress caused by the symptoms of the conditions themselves (e.g., dysphoria, metabolic issues, sensory overload) and the external pressures of "minority stress"—the chronic stress experienced as a result of social stigma, prejudice, and discrimination related to being both neurodivergent and gender-diverse.⁵³ Therefore, comprehensive clinical management must prioritize robust mental health support. This includes providing evidence-based therapies to manage anxiety and depression, fostering resilience, and addressing the unique stressors faced by individuals at the intersection of these identities.

VII. Critical Analysis and Future Research Directions

7.1. Disentangling Correlation from Causation

A paramount consideration in interpreting the existing body of research is the fundamental distinction between correlation and causation. While the evidence for a statistical association between ASD, PCOS, and GD is compelling, it is crucial to recognize that this correlation does not prove that one condition causes another.⁶ The prenatal sex steroid hypothesis posits a common causal factor, but other interpretations remain possible. For example, some psychological theories suggest that the inherent social challenges and difficulties in understanding complex social norms in autism might lead an individual to feel alienated from their assigned gender role and more readily identify with a gender-diverse identity.⁴⁹ Conversely, it is also conceivable that the profound and chronic distress of untreated gender dysphoria during childhood could impact social development in a way that produces behaviors mimicking certain autistic traits. Without longitudinal data from birth, disentangling these complex, potentially bidirectional influences remains a significant challenge.

7.2. Methodological Limitations of Current Research

The current body of evidence, while suggestive, is subject to several methodological limitations that temper the strength of its conclusions. A significant issue is the reliance on clinical populations in many studies, particularly in the research on ASD and GD.⁵⁵ Studies that recruit participants from gender identity clinics may be subject to ascertainment bias, potentially overestimating the rate of co-occurrence compared to what exists in the general population, as individuals with multiple complex conditions are more likely to seek specialized care.⁵⁶

Another major challenge is the inconsistency in diagnostic criteria used across studies and over time. This is particularly evident in the research on PCOS and gender identity, where early studies used non-standardized criteria for PCOS, leading to conflicting prevalence estimates that are difficult to synthesize.³⁹ Finally, the vast majority of existing studies are cross-sectional, providing only a static snapshot in time. There is a critical scarcity of longitudinal research that follows individuals from childhood through adolescence and into adulthood. Such studies are essential to understand the developmental trajectories of these conditions, clarify the temporal sequence of their onset, and ultimately move closer to understanding the causal pathways involved.⁵³

7.3. Proposed Avenues for Future Inquiry

To address these limitations and advance the field, several key avenues for future research are imperative.

• Prospective Longitudinal Studies: There is a pressing need for large-scale, prospective cohort studies that follow the children of mothers with and without PCOS from birth. Such studies would allow for the tracking of early neurodevelopmental milestones, the emergence of autistic traits, and the development of gender identity over time, providing invaluable data on the temporal relationships between these phenomena.

• Integrated Genetic and Endocrine Research: Future genetic studies should aim to identify specific shared risk alleles or pathways for ASD and PCOS. This could involve conducting GWAS on large cohorts of individuals with both conditions and integrating this genetic data with detailed endocrine profiling (e.g., measuring prenatal and postnatal steroid hormone levels) to build a more complete picture of the gene-hormone interactions.

• Advanced Neuroimaging: Neuroimaging studies employing techniques like fMRI and DTI could compare brain structure, function, and connectivity among four groups: individuals with ASD only, GD only, co-occurring ASD and GD, and neurotypical/cisgender controls. This would help to identify the unique and shared neural signatures of these conditions.

• Clinical Trials and Guideline Development: There is a need to move beyond expert consensus and develop evidence-based clinical guidelines for the assessment and treatment of individuals with these co-occurring conditions.² This would involve clinical trials to evaluate the safety and efficacy of tailored interventions, such as modified approaches to gender-affirming care for autistic individuals.

VIII. Conclusion: Synthesizing a Complex Biopsychosocial Phenomenon

Summary of Key Findings

This comprehensive review has synthesized a substantial and converging body of evidence demonstrating a significant, non-random association between Autism Spectrum Disorder, Polycystic Ovary Syndrome, and Gender Dysphoria. The epidemiological data are particularly robust for the links between ASD and GD, and for the bidirectional association between ASD and PCOS. The connection between PCOS and GD is more nascent but biologically plausible. The prenatal sex steroid hypothesis currently stands as the most compelling, though not yet definitive, unifying biological framework. It posits that atypical exposure to androgens during critical fetal development serves as a common etiological antecedent, capable of simultaneously influencing neurodevelopment, endocrine function, and the formation of gender identity. This theory provides a powerful, parsimonious explanation that integrates the epidemiological findings with known principles of developmental biology.

A Call for an Integrated Biopsychosocial Model

While the evidence strongly points to shared biological underpinnings, a purely biological model is insufficient to capture the full reality of these conditions. The expression, experience, and impact of ASD, PCOS, and GD are profoundly shaped by psychological and social contexts. The internal distress of gender dysphoria, the physical and emotional challenges of living with PCOS symptoms, and the social and sensory difficulties of autism are all exacerbated by societal factors. Stigma, misunderstanding, discrimination, and a lack of access to appropriate and affirming care contribute significantly to the high rates of anxiety, depression, and suicidality observed in these populations. Therefore, a comprehensive understanding requires an integrated biopsychosocial model that acknowledges the complex interplay between an individual's innate biology and their lived experience within their environment.

Final Statement on Clinical Imperatives

The convergence of these conditions carries urgent clinical imperatives. It is critical for healthcare professionals across all relevant disciplines—from endocrinology and psychiatry to primary care and developmental pediatrics—to become aware of these high rates of co-occurrence. This awareness must translate into tangible changes in clinical practice, including the adoption of routine screening, the formation of multidisciplinary care teams, and the development of person-centered management strategies that are tailored to the unique needs of this complex population. The ultimate goal of clinical care should not be to "cure" autism or to pathologize gender diversity, but rather to alleviate distress, manage co-morbid health conditions, and support individuals in achieving a healthy, authentic, and fulfilling life. Continued research, coupled with compassionate and integrated clinical care, is essential to improve the health and well-being of this vulnerable and historically underserved population.

Works cited

1. Autism Spectrum Disorder and Gender Dysphoria/Incongruence. A systematic Literature Review and Meta-Analysis - PMC, accessed September 23, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10313553/

2. Gender Dysphoria and Related Symptoms in Autism Spectrum Disorder: A Bilingual Review of the Literature - MDPI, accessed September 23, 2025, https://www.mdpi.com/2076-3425/14/12/1202

3. Prenatal hormones and sexual orientation - Wikipedia, accessed September 23, 2025, https://en.wikipedia.org/wiki/Prenatal_hormones_and_sexual_orientation

4. Polycystic ovary syndrome and autism: A test of the prenatal sex steroid theory - PMC, accessed September 23, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC6068102/

5. Link between PCOS in the mother and autism in the child | Karolinska Institutet - News, accessed September 23, 2025, https://news.ki.se/link-between-pcos-in-the-mother-and-autism-in-the-child

6. The Link Between Autism and Gender Diversity | Psychology Today, accessed September 23, 2025, https://www.psychologytoday.com/us/blog/the-venn-diagram-life/202307/the-link-between-autism-and-gender-diversity

7. Diagnostic Criteria for Autism Spectrum Disorder in the DSM-5 | CHOP Research Institute, accessed September 23, 2025, https://www.research.chop.edu/car-autism-roadmap/diagnostic-criteria-for-autism-spectrum-disorder-in-the-dsm-5

8. Autism diagnostic criteria: DSM-5, accessed September 23, 2025, https://www.autismspeaks.org/autism-diagnostic-criteria-dsm-5

9. Autism Spectrum Disorder (ASD) Symptoms & Causes - Cleveland Clinic, accessed September 23, 2025, https://my.clevelandclinic.org/health/articles/autism

10. Autism Spectrum Disorders: Diagnosis and Treatment - NCBI, accessed September 23, 2025, https://www.ncbi.nlm.nih.gov/books/NBK573609/

11. Autism spectrum disorder - Symptoms and causes - Mayo Clinic, accessed September 23, 2025, https://www.mayoclinic.org/diseases-conditions/autism-spectrum-disorder/symptoms-causes/syc-20352928

12. About Autism Spectrum Disorder - CDC, accessed September 23, 2025, https://www.cdc.gov/autism/about/index.html

13. Polycystic ovary syndrome (PCOS) - Symptoms and causes - Mayo Clinic, accessed September 23, 2025, https://www.mayoclinic.org/diseases-conditions/pcos/symptoms-causes/syc-20353439

14. Diagnosis and management of polycystic ovarian syndrome - PMC - PubMed Central, accessed September 23, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10833093/

15. Polycystic Ovarian Syndrome - StatPearls - NCBI Bookshelf, accessed September 23, 2025, https://www.ncbi.nlm.nih.gov/books/NBK459251/

16. PCOS (Polycystic Ovary Syndrome): Symptoms & Treatment - Cleveland Clinic, accessed September 23, 2025, https://my.clevelandclinic.org/health/diseases/8316-polycystic-ovary-syndrome-pcos

17. Polycystic ovary syndrome - World Health Organization (WHO), accessed September 23, 2025, https://www.who.int/news-room/fact-sheets/detail/polycystic-ovary-syndrome

18. Gender dysphoria - Diagnosis and treatment - Mayo Clinic, accessed September 23, 2025, https://www.mayoclinic.org/diseases-conditions/gender-dysphoria/diagnosis-treatment/drc-20475262

19. Gender Dysphoria - StatPearls - NCBI Bookshelf, accessed September 23, 2025, https://www.ncbi.nlm.nih.gov/books/NBK532313/

20. What is Gender Dysphoria? - American Psychiatric Association, accessed September 23, 2025, https://www.psychiatry.org/patients-families/gender-dysphoria/what-is-gender-dysphoria

21. Psychiatry.org - Gender Dysphoria Diagnosis - American Psychiatric Association, accessed September 23, 2025, https://www.psychiatry.org/psychiatrists/diversity/education/transgender-and-gender-nonconforming-patients/gender-dysphoria-diagnosis

22. Gender Incongruence and Gender Dysphoria - Psychiatric Disorders - Merck Manuals, accessed September 23, 2025, https://www.merckmanuals.com/professional/psychiatric-disorders/gender-incongruence-and-gender-dysphoria/gender-incongruence-and-gender-dysphoria

23. Table 2. [DSM-5 Criteria for Gender Dysphoria ()]. - Endotext - NCBI Bookshelf, accessed September 23, 2025, https://www.ncbi.nlm.nih.gov/books/NBK577212/table/pediat_transgender.T.dsm5_criteria_for_g/

24. Genetic link between gender dysphoria and sex hormone signaling - ResearchGate, accessed September 23, 2025, https://www.researchgate.net/publication/335806472_Genetic_link_between_gender_dysphoria_and_sex_hormone_signaling

25. Polycystic ovary syndrome (PCOS) - Diagnosis and treatment - Mayo Clinic, accessed September 23, 2025, https://www.mayoclinic.org/diseases-conditions/pcos/diagnosis-treatment/drc-20353443

26. Largest study to date confirms overlap between autism and gender diversity, accessed September 23, 2025, https://www.thetransmitter.org/spectrum/largest-study-to-date-confirms-overlap-between-autism-and-gender-diversity/

27. (PDF) Autism Spectrum Disorder and Gender Dysphoria ..., accessed September 23, 2025, https://www.researchgate.net/publication/360754997_Autism_Spectrum_Disorder_and_Gender_DysphoriaIncongruence_A_systematic_Literature_Review_and_Meta-Analysis

28. Autism and gender dysphoria occur together at significantly high rates., accessed September 23, 2025, https://statsforgender.org/there-is-a-significant-co-occurrence-of-gender-dysphoria-and-autism-spectrum-disorder-diagnoses/

29. A comparison of gender diversity in transgender young people with ..., accessed September 23, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC11127512/

30. Link between polycystic ovarian syndrome in the mother and autism in the child, accessed September 23, 2025, https://www.sciencedaily.com/releases/2015/12/151208081332.htm

31. Maternal polycystic ovary syndrome and the risk of autism spectrum ..., accessed September 23, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC5030459/

32. Maternal polycystic ovarian syndrome in autism spectrum disorder: a systematic review and meta-analysis | Request PDF - ResearchGate, accessed September 23, 2025, https://www.researchgate.net/publication/331722210_Maternal_polycystic_ovarian_syndrome_in_autism_spectrum_disorder_a_systematic_review_and_meta-analysis

33. Associations of Maternal Androgen-Related Conditions With Risk of Autism Spectrum Disorder in Progeny and Mediation by Cardiovascular, Metabolic, and Fertility Factors - PMC - PubMed Central, accessed September 23, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC8024051/

34. Is There a Link Between PCOS and Autism?, accessed September 23, 2025, https://www.autismparentingmagazine.com/autism-pcos-link/

35. Polycystic ovary syndrome and autism: A test of the prenatal sex steroid theory, accessed September 23, 2025, https://docs.autismresearchcentre.com/papers/2018_Cherskov_Polycystic-overy-syndrome-and-autism.pdf

36. Women with polycystic ovary syndrome more likely to have a child with autism, accessed September 23, 2025, https://www.cam.ac.uk/research/news/women-with-polycystic-ovary-syndrome-more-likely-to-have-a-child-with-autism

37. Hyperandrogenism-related metabolic changes in drug-naïve transmen compared to cisgender women: a case-controlled study - Via Medica Journals, accessed September 23, 2025, https://journals.viamedica.pl/endokrynologia_polska/article/download/EP.a2023.0052/73018

38. (PDF) Polycystic Ovary Syndrome and Gender Identity - ResearchGate, accessed September 23, 2025, https://www.researchgate.net/publication/345670288_Polycystic_Ovary_Syndrome_and_Gender_Identity

39. Polycystic Ovary Syndrome and Gender Identity - PMC, accessed September 23, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC7513432/

40. Social Repercussions of Polycystic Ovary Syndrome (PCOS): Analyzing Gender Roles and Societal Perceptions - Stanford University Student Journals, accessed September 23, 2025, https://ojs.stanford.edu/ojs/index.php/intersect/article/download/2595/1578/9679

41. Severe Hyperandrogenism Secondary to Polycystic Ovarian Syndrome in a Gender-diverse Adolescent - PMC, accessed September 23, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC12418000/

42. Transgender Identity Among Adolescents with PCOS - Children's Mercy Kansas City, accessed September 23, 2025, https://scholarlyexchange.childrensmercy.org/cgi/viewcontent.cgi?filename=0&article=1185&context=researchdays&type=additional

43. Fetal testosterone and autistic traits: A response to three fascinating commentaries | Request PDF - ResearchGate, accessed September 23, 2025, https://www.researchgate.net/publication/23784694_Fetal_testosterone_and_autistic_traits_A_response_to_three_fascinating_commentaries

44. Sex and gender in neurodevelopmental conditions - PMC - PubMed Central, accessed September 23, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10154737/

45. A CRH Theory of Autism Spectrum Disorder - arXiv, accessed September 23, 2025, https://arxiv.org/html/2408.06750v1

46. Towards a further understanding of prenatal thyroid theory of homosexuality: Autoimmune thyroiditis, polycystic ovary syndrome, autism and low birth weight - ResearchGate, accessed September 23, 2025, https://www.researchgate.net/publication/339158795_Towards_a_further_understanding_of_prenatal_thyroid_theory_of_homosexuality_Autoimmune_thyroiditis_polycystic_ovary_syndrome_autism_and_low_birth_weight

47. Endocrine Disruptors and Autism Spectrum Disorder in Pregnancy: A Review and Evaluation of the Quality of the Epidemiological Evidence - MDPI, accessed September 23, 2025, https://www.mdpi.com/2227-9067/5/12/157

48. Investigating gender dysphoria in autism spectrum disorder: clinical challenges and future perspectives | Journal of Psychopathology, accessed September 23, 2025, https://www.jpsychopathol.it/article/view/283

49. (PDF) Gender Dysphoria and Co-Occurring Autism Spectrum Disorders: Review, Case Examples, and Treatment Considerations - ResearchGate, accessed September 23, 2025, https://www.researchgate.net/publication/286550753_Gender_Dysphoria_and_Co-Occurring_Autism_Spectrum_Disorders_Review_Case_Examples_and_Treatment_Considerations

50. Autism Spectrum Disorder and Gender Dysphoria/Incongruence: A Systematic Literature Review and Meta-Analysis - MedCentral, accessed September 23, 2025, https://www.medcentral.com/psychiatry/autism/autism-spectrum-disorder-and-gender-dysphoria-meta-analysis

51. Initial Clinical Guidelines for Co-Occurring Autism Spectrum Disorder and Gender Dysphoria or Incongruence in Adolescents - PubMed, accessed September 23, 2025, https://pubmed.ncbi.nlm.nih.gov/27775428/

52. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline | The Journal of Clinical Endocrinology & Metabolism | Oxford Academic, accessed September 23, 2025, https://academic.oup.com/jcem/article/102/11/3869/4157558

53. Gender Discomfort and Autism, accessed September 23, 2025, https://autism.org/gender-discomfort-and-autism/

54. Common Co-occurring Conditions and Impacts of Gender-Affirming Care on Chronic Conditions in Transgender and Gender Diverse Populations - NCBI, accessed September 23, 2025, https://www.ncbi.nlm.nih.gov/books/NBK610258/

55. Gender dysphoria and autism spectrum disorder: a systematic review of the literature - Loughborough University Research Repository, accessed September 23, 2025, https://repository.lboro.ac.uk/ndownloader/files/17268089/1

56. Autistic traits, behavioral problems in 7-year-olds linked with gender nonconforming play, accessed September 23, 2025, https://www.eurekalert.org/news-releases/1055106